New guidelines have been set for how information about using medications during pregnancy and lactation is listed on prescription drugs and biological products to better communicate risks and benefits of using these medical products during pregnancy and breastfeeding. The new guidelines, established by the Food and Drug Administration (FDA) replace the decades-old product letter categories – A, B, C, D and X – that have been used to classify risks of prescription drugs during pregnancy. The new format involves three detailed subsets that describe the risks within the real-world context of caring for pregnant women who may need medication. FDA ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.